Two Sigma Investments
MIRA icon

Two Sigma Investments’s MIRA Pharmaceuticals MIRA Stock Holding History

Two Sigma Investments’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,044
Closed -$40.8K – 4794
2025
Q4 		$40.8K Sell
27,044
-18,659
-41% -$27.4K ﹤0.01% 3954
2025
Q3 		$62.2K Buy
45,703
+25,816
+130% +$37.5K ﹤0.01% 3523
2025
Q2 		$24.1K Sell
19,887
-2,487
-11% -$2.87K ﹤0.01% 3108
2025
Q1 		$21.9K Sell
22,374
-1,943
-8% -$2.21K ﹤0.01% 3094
2024
Q4 		$27.7K Buy
+24,317
New +$31.8K ﹤0.01% 3086

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Investments's MIRA Position: Q1 2026 in Review

Two Sigma Investments sold out of MIRA Pharmaceuticals (MIRA) in Q1 2026, closing a stake of 27,044 shares — an estimated $40.8K sold.

Two Sigma Investments first reported a position in MIRA in Q4 2024 and held it in 5 quarters. The position peaked at $62.2K in Q3 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Two Sigma Investments reported no remaining MIRA Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 27,044 MIRA Pharmaceuticals shares in Q1 2026, an estimated $40.8K.
  • Two Sigma Investments first reported a position in MIRA Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Two Sigma Investments's MIRA Pharmaceuticals position peaked at $62.2K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.